Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,7.582980734471203e-38,20.9617126638082,1791.6463629426294,"['RPL30', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPS14', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPL21', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL26', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPS3', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.1621029662744915e-35,0,0,55
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.224065359067399e-07,4.2801468846244966,65.56653812621552,"['UQCRB', 'NDUFB10', 'NDUFA4', 'COX4I1', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'ATP5MC3', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5F1E', 'ATP5MC1', 'UQCRQ', 'NDUFS6', 'UQCRFS1', 'SLC25A5', 'ATP5MF']",4.637176273655527e-05,0,0,23
3,Complement system WP2806,3.1470095339027345e-05,5.950449293966624,61.68517085705245,"['FCGR3A', 'SELPLG', 'RPS19', 'CD93', 'PROS1', 'ITGAX', 'F13A1', 'VSIG4', 'CALR', 'CD55', 'TLR2']",0.004374343252124801,0,0,11
4,Nonalcoholic fatty liver disease WP4396,6.776106751231044e-05,2.80684811237928,26.94440232020881,"['NDUFA13', 'XBP1', 'UQCRB', 'NDUFB10', 'NDUFA4', 'INSR', 'COX4I1', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRQ', 'NDUFS6', 'MLX', 'CYCS', 'UQCRFS1']",0.007064091288158364,0,0,23
5,"GPCRs, Class A Rhodopsin-like WP455",0.00019278141157089433,6.8263214670981665,58.392037043528525,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'GPR34', 'HRH2', 'GPR65']",0.01607796972501259,0,0,8
6,Mitochondrial complex III assembly WP4921,0.0005085380291257185,8.755299539170506,66.39993393502023,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.03534339302423744,0,0,6
7,Photodynamic therapy-induced unfolded protein response WP3613,0.0018763370067625927,6.125806451612903,38.46047029889345,"['DNAJC3', 'XBP1', 'HSPA5', 'DNAJB11', 'CALR', 'HSP90B1']",0.11177607597428588,0,0,6
8,Mitochondrial CIV Assembly WP4922,0.0023487073746657366,4.768443726440496,28.86763453252825,"['PET100', 'NDUFA4', 'COX4I1', 'COX14', 'COX5B', 'COX6C', 'COX7C']",0.12242637190445152,0,0,7
9,Insulin signaling in adipocytes (diabetic condition) WP3635,0.0062904519088494435,15.260032102728731,77.34886601348093,"['TBC1D4', 'INSR', 'RPS6']",0.2623118445990218,0,0,3
10,Insulin signaling in adipocytes (normal condition) WP3634,0.0062904519088494435,15.260032102728731,77.34886601348093,"['TBC1D4', 'INSR', 'RPS6']",0.2623118445990218,0,0,3
11,Monoamine GPCRs WP58,0.008063896552390657,inf,inf,"['CHRM3', 'HRH2']",0.27208481810000223,0,0,2
12,Differentiation Pathway WP2848,0.008732343106850074,6.788853161843516,32.184062470719375,"['WNT2B', 'WNT5A', 'PDGFB', 'IGF1']",0.27208481810000223,0,0,4
13,PI3K-Akt signaling pathway WP4172,0.011640154087182176,1.8691869186918693,8.32404000959931,"['IFNAR2', 'CDKN1A', 'HSP90AA1', 'IL4R', 'ANGPT2', 'INSR', 'RPS6', 'PDGFB', 'IGF1', 'HSP90B1', 'GNG10', 'CCND3', 'GNG3', 'FGF14', 'DDIT4', 'FGF20', 'SGK1', 'JAK3', 'TLR4', 'TLR2']",0.27208481810000223,0,0,20
14,Genes targeted by miRNAs in adipocytes WP1992,0.01174466840719434,10.171749598715891,45.206875280816455,"['HDAC4', 'TMSB4X', 'IGF1']",0.27208481810000223,0,0,3
15,Kynurenine Pathway and links to Cellular Senescence WP5044,0.01174466840719434,10.171749598715891,45.206875280816455,"['CDKN1A', 'KYNU', 'TLR4']",0.27208481810000223,0,0,3
16,Macrophage markers WP4146,0.01174466840719434,10.171749598715891,45.206875280816455,"['CD163', 'CD83', 'CD14']",0.27208481810000223,0,0,3
17,Platelet-mediated interactions with vascular and circulating cells WP4462,0.01174466840719434,10.171749598715891,45.206875280816455,"['SELPLG', 'TLR4', 'TLR2']",0.27208481810000223,0,0,3
18,Pyrimidine metabolism and related diseases WP4225,0.01174466840719434,10.171749598715891,45.206875280816455,"['NT5C', 'DPYD', 'TYMP']",0.27208481810000223,0,0,3
19,Selenium Micronutrient Network WP15,0.0178250468016108,2.9760366182014,11.984947911732004,"['SELENOM', 'PRDX5', 'KYNU', 'INSR', 'SELENOW', 'PLAT', 'SELENOH']",0.3450253906899085,0,0,7
20,Lung fibrosis WP3624,0.018392706428461685,3.918617614269788,15.658016505817471,"['CEBPB', 'FAM13A', 'PDGFB', 'HMOX1', 'IGF1']",0.3450253906899085,0,0,5
21,Biomarkers for pyrimidine metabolism disorders WP4584,0.019193682873094635,7.62760834670947,30.153263540814685,"['NT5C', 'DPYD', 'TYMP']",0.3450253906899085,0,0,3
22,Development and heterogeneity of the ILC family WP3893,0.019193682873094635,7.62760834670947,30.153263540814685,"['IL15', 'ZBTB16', 'RORA']",0.3450253906899085,0,0,3
23,Spinal Cord Injury WP2431,0.019385768802186686,2.484865740943537,9.798362469304545,"['C1QB', 'ZFP36', 'GAP43', 'FCGR2A', 'APEX1', 'TNFSF13', 'MIF', 'TLR4', 'TNFSF13B']",0.3450253906899085,0,0,9
24,Endochondral Ossification with Skeletal Dysplasias WP4808,0.02068497546102569,3.2195246179966044,12.486435785862499,"['HDAC4', 'SCIN', 'ENPP1', 'PLAT', 'IGF1', 'CALM2']",0.3450253906899085,0,0,6
25,Endochondral Ossification WP474,0.02068497546102569,3.2195246179966044,12.486435785862499,"['HDAC4', 'SCIN', 'ENPP1', 'PLAT', 'IGF1', 'CALM2']",0.3450253906899085,0,0,6
26,Oxidative phosphorylation WP623,0.022134093103140767,2.419090676448008,9.21827446600416,"['NDUFB10', 'NDUFS6', 'NDUFA4', 'NDUFA3', 'NDUFB2', 'ATP5MC3', 'ATP5MF', 'ATP5F1E', 'ATP5MC1']",0.35499680092345004,0,0,9
27,NRF2 pathway WP2884,0.031050770905871113,2.4009137635636777,8.336288650642507,"['DNAJB1', 'HSP90AA1', 'FTH1', 'PDGFB', 'HMOX1', 'NRG1', 'SLC5A3', 'HSPA1A']",0.4642794035331544,0,0,8
28,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.031174636208461205,4.070739549839228,14.117937229369227,"['FCGR2A', 'NLRP3', 'TMEM173', 'IKBKE']",0.4642794035331544,0,0,4
29,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.03493145658786734,3.1823671497584543,10.674829006525902,"['IFNAR2', 'OAS1', 'IKBKE', 'TLR4', 'TLR2']",0.4671224219161922,0,0,5
30,Nuclear Receptors Meta-Pathway WP2882,0.036028312353093554,1.7428671084757585,5.792332032161653,"['HSP90AA1', 'STAT3', 'PDGFB', 'NRG1', 'SLC5A3', 'SLC7A5', 'DNAJB1', 'SEC14L1', 'FTH1', 'BHLHE40', 'PDE4B', 'HMOX1', 'PLTP', 'CPEB4', 'HSPA1A', 'FKBP5']",0.4671224219161922,0,0,16
31,Complement and Coagulation Cascades WP558,0.03957382391341983,3.7000876936568257,11.949756563152294,"['C1QB', 'PROS1', 'PLAT', 'CD55']",0.4671224219161922,0,0,4
32,MECP2 and Associated Rett Syndrome WP3584,0.03984528271725987,2.2668104998202088,7.305366387067339,"['RBFOX1', 'CEBPD', 'BCL6', 'RPS6', 'NREP', 'IGF1', 'SGK1', 'FKBP5']",0.4671224219161922,0,0,8
33,LTF danger signal response pathway WP4478,0.04021518593379864,5.08346709470305,16.33577536888959,"['CD14', 'TLR4', 'TLR2']",0.4671224219161922,0,0,3
34,Glucocorticoid Receptor Pathway WP2880,0.04089928939127453,2.657924263674614,8.496433903268752,"['HSP90AA1', 'MGAM', 'SEC14L1', 'BHLHE40', 'PDE4B', 'CPEB4']",0.4671224219161922,0,0,6
35,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.04197762147943961,2.994695462726153,9.49503720917531,"['IRAK2', 'LY96', 'PLAT', 'CD14', 'TLR4']",0.4671224219161922,0,0,5
36,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.04197762147943961,2.994695462726153,9.49503720917531,"['NDUFA13', 'HSP90AA1', 'CASP1', 'NLRP3', 'NLRP1']",0.4671224219161922,0,0,5
37,Caloric restriction and aging WP4191,0.042797117616929115,10.157051282051283,32.00775851522257,"['NAMPT', 'IGF1']",0.4671224219161922,0,0,2
38,Inflammatory Response Pathway WP453,0.042797117616929115,10.157051282051283,32.00775851522257,"['IL4R', 'TNFRSF1B']",0.4671224219161922,0,0,2
39,Mitochondrial complex I assembly model OXPHOS system WP4324,0.04379265439339993,2.378567582121702,7.440847239559466,"['NDUFA13', 'NDUFB10', 'NDUFS6', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1']",0.4671224219161922,0,0,7
40,ESC Pluripotency Pathways WP3931,0.04480790617901124,2.205195486748885,6.847949403634588,"['FGF14', 'WNT2B', 'WNT5A', 'STAT3', 'PDGFB', 'FGF20', 'GAB1', 'MAP2K6']",0.4671224219161922,0,0,8
41,"GPCRs, Other WP117",0.05370785214726516,4.356569594129787,12.739463666994189,"['CHRM3', 'ADGRE2', 'P2RY13']",0.509003962395672,0,0,3
42,IL1 and megakaryocytes in obesity WP2865,0.05370785214726516,4.356569594129787,12.739463666994189,"['NLRP3', 'PLA2G7', 'TLR2']",0.509003962395672,0,0,3
43,Iron metabolism in placenta WP2007,0.05370785214726516,4.356569594129787,12.739463666994189,"['FTH1', 'SLC40A1', 'HAMP']",0.509003962395672,0,0,3
44,Nucleotide metabolism WP404,0.05370785214726516,4.356569594129787,12.739463666994189,"['POLB', 'OAZ1', 'SRM']",0.509003962395672,0,0,3
45,Calcium Regulation in the Cardiac Cell WP536,0.05680497478532936,1.776235660671293,5.094477223931276,"['RGS4', 'CHRM3', 'RYR2', 'GNG3', 'CACNA1B', 'RGS10', 'CALM3', 'CALR', 'PKIG', 'CALM2', 'RGS6', 'YWHAH']",0.5263927663440521,0,0,12
46,Toll-like Receptor Signaling Pathway WP75,0.0661049858935772,1.9120745542949757,5.194171761122376,"['IFNAR2', 'LY96', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.5340588334595832,0,0,9
47,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.06713493483799729,6.770299145299146,18.286921462739304,"['CASP1', 'NLRP3']",0.5340588334595832,0,0,2
48,Complement Activation WP545,0.06713493483799729,6.770299145299146,18.286921462739304,"['C1QB', 'CD55']",0.5340588334595832,0,0,2
49,Nanomaterial-induced inflammasome activation WP3890,0.06713493483799729,6.770299145299146,18.286921462739304,"['CASP1', 'TLR4']",0.5340588334595832,0,0,2
50,Tryptophan catabolism leading to NAD+ production WP4210,0.06713493483799729,6.770299145299146,18.286921462739304,"['KYNU', 'NAMPT']",0.5340588334595832,0,0,2
51,NO/cGMP/PKG mediated Neuroprotection WP4008,0.06790765162914485,2.5442834138486314,6.843121363155581,"['GUCY1A1', 'TSPO', 'CYCS', 'GRIN2B', 'CALM2']",0.5340588334595832,0,0,5
52,Genes controlling nephrogenesis WP4823,0.069063138235385,3.8113964686998396,10.186849485439314,"['ROBO2', 'CXCL12', 'PDGFB']",0.5340588334595832,0,0,3
53,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.069063138235385,3.8113964686998396,10.186849485439314,"['IL4R', 'STAT3', 'TLR4']",0.5340588334595832,0,0,3
54,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.06915869785807552,1.5522519352568613,4.1466104522817915,"['IFNAR2', 'CDKN1A', 'HSP90AA1', 'IL4R', 'ANGPT2', 'INSR', 'RPS6', 'PDGFB', 'IGF1', 'HSP90B1', 'GNG10', 'GNG3', 'FGF14', 'DDIT4', 'FGF20', 'ITGAX', 'JAK3']",0.5340588334595832,0,0,17
55,Myometrial relaxation and contraction pathways WP289,0.07122895586608578,1.701411509229099,4.494883965460607,"['RGS4', 'RYR2', 'GUCY1A1', 'GNG3', 'PDE4B', 'RGS10', 'CALM3', 'PKIG', 'CALM2', 'RGS6', 'ACTG1', 'YWHAH']",0.540044992657414,0,0,12
56,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.08614959538595661,3.3873729266987693,8.304720626022407,"['STAT3', 'IGF1', 'TLR4']",0.6075882385419317,0,0,3
57,Statin inhibition of cholesterol production WP430,0.08614959538595661,3.3873729266987693,8.304720626022407,"['APOC2', 'APOC1', 'PLTP']",0.6075882385419317,0,0,3
58,CAMKK2  Pathway WP4874,0.08916153495061353,2.3122529644268774,5.589421935303431,"['HDAC4', 'CHRM3', 'MAP1LC3A', 'HMOX1', 'CALM2']",0.6075882385419317,0,0,5
59,"COVID-19, thrombosis and anticoagulation WP4927",0.08986481008497843,inf,inf,['F13A1'],0.6075882385419317,0,0,1
60,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.08986481008497843,inf,inf,['HRH2'],0.6075882385419317,0,0,1
61,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.0948300996263463,5.076923076923077,11.959547330121032,"['TLR4', 'TLR2']",0.6075882385419317,0,0,2
62,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.0948300996263463,5.076923076923077,11.959547330121032,"['CDKN1A', 'ENPP1']",0.6075882385419317,0,0,2
63,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.0948300996263463,5.076923076923077,11.959547330121032,"['GRM5', 'GRM7']",0.6075882385419317,0,0,2
64,Transcriptional cascade regulating adipogenesis WP4211,0.0948300996263463,5.076923076923077,11.959547330121032,"['CEBPB', 'CEBPD']",0.6075882385419317,0,0,2
65,Toll-like Receptor Signaling related to MyD88 WP3858,0.09862053938536662,2.5418006430868165,5.888019497338516,"['TLR5', 'IKBKE', 'TLR4', 'TLR2']",0.6075882385419317,0,0,4
66,Adipogenesis WP236,0.09894790192388465,1.8108594030924128,4.188810815518114,"['CDKN1A', 'CEBPB', 'CEBPD', 'NAMPT', 'STAT3', 'RORA', 'MIF', 'IGF1']",0.6075882385419317,0,0,8
67,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.09894790192388465,1.8108594030924128,4.188810815518114,"['HDAC4', 'WNT5A', 'STAT3', 'NRG1', 'IGF1', 'IKBKE', 'CALM2', 'MAP2K6']",0.6075882385419317,0,0,8
68,Regulatory circuits of the STAT3 signaling pathway WP4538,0.09907913722026702,2.035483870967742,4.705705668506375,"['PTPRT', 'IFNAR2', 'STMN1', 'STAT3', 'JAK3', 'CSF2RA']",0.6075882385419317,0,0,6
69,Ferroptosis WP4313,0.10093637878084621,2.2113701603304627,5.071257511390828,"['MAP1LC3A', 'ACSL1', 'FTH1', 'SLC40A1', 'HMOX1']",0.6100068108929402,0,0,5
70,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.10481644473246736,3.048154093097913,6.8752475169053895,"['TLR5', 'TLR4', 'TLR2']",0.6156120768089984,0,0,3
71,Transcription factor regulation in adipogenesis WP3599,0.10481644473246736,3.048154093097913,6.8752475169053895,"['CEBPB', 'CEBPD', 'INSR']",0.6156120768089984,0,0,3
72,VEGFA-VEGFR2 Signaling Pathway WP3888,0.11263715980423047,1.2961413136683244,2.8302329180075074,"['HDAC4', 'PXN', 'ARPC5L', 'HTRA1', 'IQGAP1', 'LDB2', 'RPL10A', 'SLC7A1', 'RPL7', 'ACTG1', 'RPS6KA5', 'RPL18A', 'TMSB4X', 'RPLP2', 'RPS11', 'TMSB10', 'MAP2K6', 'TMOD1', 'PTPN1', 'HSP90AA1', 'SEMA6D', 'STAT3', 'RPS6', 'GAB1', 'PTPN14', 'FMNL3', 'TXNIP', 'CYCS', 'RPL26', 'CALR', 'HSPA1A']",0.6401863699124334,0,0,31
73,Melatonin metabolism and effects WP3298,0.11360621432498817,2.3919046718365804,5.202433492555204,"['PER2', 'PER3', 'CALM2', 'ARNTL']",0.6401863699124334,0,0,4
74,Oxidative Damage WP3941,0.11360621432498817,2.3919046718365804,5.202433492555204,"['C1QB', 'CDKN1A', 'CYCS', 'TNFRSF1B']",0.6401863699124334,0,0,4
75,Retinoblastoma gene in cancer WP2446,0.12104525247563924,1.9076612903225807,4.028200060491724,"['CDKN1A', 'CCND3', 'TFDP2', 'H2AFZ', 'STMN1', 'SAP30']",0.6602571633435637,0,0,6
76,NRF2-ARE regulation WP4357,0.12490058618563156,2.770611411060849,5.763528837096953,"['CEBPB', 'INSR', 'HMOX1']",0.6602571633435637,0,0,3
77,White fat cell differentiation WP4149,0.12490058618563156,2.770611411060849,5.763528837096953,"['CEBPB', 'CEBPD', 'RORA']",0.6602571633435637,0,0,3
78,Dual hijack model of Vif in HIV infection WP3300,0.1250846904176056,4.060897435897436,8.441648403540754,"['ELOB', 'RUNX1']",0.6602571633435637,0,0,2
79,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.1250846904176056,4.060897435897436,8.441648403540754,"['STAT3', 'HMOX1']",0.6602571633435637,0,0,2
80,Immune response to tuberculosis WP4197,0.14623228655743534,2.539325842696629,4.882003543978621,"['IFNAR2', 'OAS1', 'PTPN2']",0.6817584104236931,0,0,3
81,SARS-CoV-2 mitochondrial interactions WP5038,0.14623228655743534,2.539325842696629,4.882003543978621,"['CTSL', 'TMEM173', 'IKBKE']",0.6817584104236931,0,0,3
82,TYROBP causal network in microglia WP3945,0.14648254076713896,1.6957458266020462,3.2572717317136175,"['IGSF6', 'DPYD', 'ITGAX', 'TCIRG1', 'SLC1A5', 'TNFRSF1B', 'GAL3ST4']",0.6817584104236931,0,0,7
83,Base Excision Repair WP4752,0.15721670527040527,3.3835470085470085,6.260002290501471,"['POLB', 'APEX1']",0.6817584104236931,0,0,2
84,Cori Cycle WP1946,0.15721670527040527,3.3835470085470085,6.260002290501471,"['TPI1', 'PGAM1']",0.6817584104236931,0,0,2
85,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.15721670527040527,3.3835470085470085,6.260002290501471,"['CYSLTR1', 'LTC4S']",0.6817584104236931,0,0,2
86,Fluoropyrimidine Activity WP1601,0.15721670527040527,3.3835470085470085,6.260002290501471,"['DPYD', 'TYMP']",0.6817584104236931,0,0,2
87,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.15721670527040527,3.3835470085470085,6.260002290501471,"['STAT3', 'JAK3']",0.6817584104236931,0,0,2
88,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.15721670527040527,3.3835470085470085,6.260002290501471,"['PDGFB', 'IGF1']",0.6817584104236931,0,0,2
89,Overview of nanoparticle effects WP3287,0.15721670527040527,3.3835470085470085,6.260002290501471,"['CCND3', 'HMOX1']",0.6817584104236931,0,0,2
90,Proteoglycan biosynthesis WP4784,0.15721670527040527,3.3835470085470085,6.260002290501471,"['CSGALNACT1', 'CHSY1']",0.6817584104236931,0,0,2
91,Cardiac Hypertrophic Response WP2795,0.15802856157811573,1.7433179723502303,3.2163859084337374,"['HDAC4', 'NRG1', 'IGF1', 'IKBKE', 'CALM2', 'MAP2K6']",0.6817584104236931,0,0,6
92,Regulation of toll-like receptor signaling pathway WP1449,0.15952590578225115,1.4973262032085561,2.748415541975955,"['IFNAR2', 'IRAK2', 'LY96', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.6817584104236931,0,0,10
93,Bladder cancer WP2828,0.16863974648728158,2.343622669465366,4.171626126858435,"['CDKN1A', 'RPS6KA5', 'TYMP']",0.6817584104236931,0,0,3
94,Unfolded protein response WP4925,0.16863974648728158,2.343622669465366,4.171626126858435,"['XBP1', 'HSPA5', 'TXNIP']",0.6817584104236931,0,0,3
95,Allograft Rejection WP2328,0.17013344995976093,1.8150448585231194,3.2147569046341715,"['C1QB', 'CXCL12', 'GNLY', 'LRRK2', 'CD55']",0.6817584104236931,0,0,5
96,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.17013344995976093,1.8150448585231194,3.2147569046341715,"['BEX3', 'CDKN1A', 'HSPA5', 'NRG1', 'YBX3']",0.6817584104236931,0,0,5
97,Pyrimidine metabolism WP4022,0.17013344995976093,1.8150448585231194,3.2147569046341715,"['NT5C', 'DPYD', 'ENPP1', 'POLR2I', 'TYMP']",0.6817584104236931,0,0,5
98,Pathogenic Escherichia coli infection WP2272,0.17133854746227065,1.6946236559139785,2.9895090958262256,"['ARPC5L', 'LY96', 'CD14', 'TLR5', 'TLR4', 'ACTG1']",0.6817584104236931,0,0,6
99,Blood Clotting Cascade WP272,0.1716657867973328,10.1424,17.872996029365936,['PLAT'],0.6817584104236931,0,0,1
100,Dopaminergic Neurogenesis WP2855,0.1716657867973328,10.1424,17.872996029365936,['STAT3'],0.6817584104236931,0,0,1
101,Hfe effect on hepcidin production WP3924,0.1716657867973328,10.1424,17.872996029365936,['HAMP'],0.6817584104236931,0,0,1
102,NAD Biosynthesis II (from tryptophan) WP2485,0.1716657867973328,10.1424,17.872996029365936,['KYNU'],0.6817584104236931,0,0,1
103,Nephrogenesis WP5052,0.1716657867973328,10.1424,17.872996029365936,['FGF20'],0.6817584104236931,0,0,1
104,Osteoblast Signaling WP322,0.1716657867973328,10.1424,17.872996029365936,['PDGFB'],0.6817584104236931,0,0,1
105,Thyroxine (Thyroid Hormone) Production WP1981,0.1716657867973328,10.1424,17.872996029365936,['TG'],0.6817584104236931,0,0,1
106,Acute viral myocarditis WP4298,0.18509429974915234,1.648561464690497,2.7809416107854683,"['STAT3', 'CASP1', 'CYCS', 'TLR5', 'TLR4', 'CD55']",0.7281539905226088,0,0,6
107,Leptin Insulin Overlap WP3935,0.19064572264643045,2.8997252747252746,4.805826130080416,"['INSR', 'STAT3']",0.7293510673721239,0,0,2
108,miRNAs involved in DNA damage response WP1545,0.19064572264643045,2.8997252747252746,4.805826130080416,"['CDKN1A', 'CCND3']",0.7293510673721239,0,0,2
109,Phytochemical activity on NRF2 transcriptional activation WP3,0.19064572264643045,2.8997252747252746,4.805826130080416,"['CEBPB', 'HMOX1']",0.7293510673721239,0,0,2
110,Phosphodiesterases in neuronal function WP4222,0.20106053300571214,1.8468284127448114,2.9625884261664863,"['GUCY1A1', 'PDE4B', 'PDE5A', 'GRIN2B']",0.7622022023943815,0,0,4
111,IL-18 signaling pathway WP4754,0.2131443645470136,1.3076992264795826,2.02142260076642,"['CEBPB', 'NRN1', 'CD83', 'SEMA6D', 'TNFAIP2', 'PLA2G7', 'GRIN2B', 'GRM7', 'TMSB4X', 'STMN1', 'HMOX1', 'CYCS', 'KIFC3', 'RPS11']",0.7750003490776369,0,0,14
112,Fatty acid beta-oxidation WP143,0.21600533090033122,2.030497592295345,3.1116404851655206,"['TPI1', 'GK', 'ACSL1']",0.7750003490776369,0,0,3
113,IL17 signaling pathway WP2112,0.21600533090033122,2.030497592295345,3.1116404851655206,"['CEBPB', 'CEBPD', 'STAT3']",0.7750003490776369,0,0,3
114,Regulation of Actin Cytoskeleton WP51,0.2199350336830305,1.3746051246051245,2.08173372340002,"['CHRM3', 'FGF14', 'TMSB4X', 'PXN', 'PDGFB', 'FGF20', 'IQGAP1', 'CD14', 'SSH2', 'ACTG1']",0.7750003490776369,0,0,10
115,Apoptosis Modulation by HSP70 WP384,0.22488019721437427,2.5368589743589745,3.7854691884153397,"['CYCS', 'HSPA1A']",0.7750003490776369,0,0,2
116,Cardiac Progenitor Differentiation WP2406,0.22488019721437427,2.5368589743589745,3.7854691884153397,"['NRG1', 'IGF1']",0.7750003490776369,0,0,2
117,Development of ureteric collection system WP5053,0.22488019721437427,2.5368589743589745,3.7854691884153397,"['ROBO2', 'GRIP1']",0.7750003490776369,0,0,2
118,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.22488019721437427,2.5368589743589745,3.7854691884153397,"['OAS1', 'TMEM173']",0.7750003490776369,0,0,2
119,Striated Muscle Contraction Pathway WP383,0.22488019721437427,2.5368589743589745,3.7854691884153397,"['TMOD1', 'ACTG1']",0.7750003490776369,0,0,2
120,Vitamin B12 metabolism WP1533,0.22488019721437427,2.5368589743589745,3.7854691884153397,"['INSR', 'PLAT']",0.7750003490776369,0,0,2
121,Wnt signaling in kidney disease WP4150,0.22488019721437427,2.5368589743589745,3.7854691884153397,"['WNT2B', 'WNT5A']",0.7750003490776369,0,0,2
122,Cellular Proteostasis WP4918,0.2461253714272447,5.0704,7.108265926617632,['PFDN5'],0.8018303116028206,0,0,1
123,EV release from cardiac cells and their functional effects WP3297,0.2461253714272447,5.0704,7.108265926617632,['CXCL12'],0.8018303116028206,0,0,1
124,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2461253714272447,5.0704,7.108265926617632,['CEBPB'],0.8018303116028206,0,0,1
125,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.2461253714272447,5.0704,7.108265926617632,['CDKN1A'],0.8018303116028206,0,0,1
126,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.2461253714272447,5.0704,7.108265926617632,['STAT3'],0.8018303116028206,0,0,1
127,miR-517 relationship with ARCN1 and USP1 WP3596,0.2461253714272447,5.0704,7.108265926617632,['CDKN1A'],0.8018303116028206,0,0,1
128,Sulfation Biotransformation Reaction WP692,0.2461253714272447,5.0704,7.108265926617632,['SULT4A1'],0.8018303116028206,0,0,1
129,Gastric Cancer Network 2 WP2363,0.2595062130311516,2.2546296296296298,3.0414381802158057,"['RNF144B', 'S100A6']",0.8260617620915284,0,0,2
130,Pre-implantation embryo WP3527,0.2595062130311516,2.2546296296296298,3.0414381802158057,"['ESRRA', 'ZFP36']",0.8260617620915284,0,0,2
131,Type II diabetes mellitus WP1584,0.2595062130311516,2.2546296296296298,3.0414381802158057,"['GK', 'INSR']",0.8260617620915284,0,0,2
132,Ectoderm Differentiation WP2858,0.2646033934850487,1.354908306364617,1.8013820304648749,"['PLCXD3', 'ZBTB16', 'ARHGDIG', 'PIM1', 'SORCS1', 'LDB2', 'KIFC3', 'CDH8']",0.835906174873222,0,0,8
133,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.27045765209535966,1.4933219664677466,1.9527271586119814,"['EIF4A2', 'RPS6KA5', 'RPS6', 'PIM1', 'MAP2K6']",0.8479762475471051,0,0,5
134,MAPK Signaling Pathway WP382,0.2774515271136191,1.227405904890692,1.5736682041040582,"['LRRK2', 'PDGFB', 'CACNA1B', 'RASGRP3', 'RPS6KA5', 'FGF14', 'DUSP10', 'STMN1', 'FGF20', 'MAP3K8', 'CD14', 'HSPA1B', 'HSPA1A', 'MAP2K6']",0.8634125881073073,0,0,14
135,Genotoxicity pathway WP4286,0.2814070100750083,1.5617116002968092,1.9801772572850007,"['PLK3', 'CDKN1A', 'RPS27', 'CEBPD']",0.8692349866761367,0,0,4
136,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.2912250432200817,1.38475073313783,1.7083101580099724,"['RPS6', 'STAT3', 'GAB1', 'PDGFB', 'NRG1', 'IGF1']",0.8840583504106657,0,0,6
137,Purinergic signaling WP4900,0.29417753565209953,2.0288461538461537,2.4824390035486084,"['P2RY12', 'P2RY13']",0.8840583504106657,0,0,2
138,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.29417753565209953,2.0288461538461537,2.4824390035486084,"['P4HA1', 'P3H2']",0.8840583504106657,0,0,2
139,Apoptosis WP254,0.30645323721059187,1.4099123277867238,1.6674893597258522,"['CASP4', 'CASP1', 'CYCS', 'IGF1', 'TNFRSF1B']",0.8840583504106657,0,0,5
140,MET in type 1 papillary renal cell carcinoma WP4205,0.30645323721059187,1.4099123277867238,1.6674893597258522,"['CDKN1A', 'RPL11', 'STAT3', 'GAB1', 'JAK3']",0.8840583504106657,0,0,5
141,7q11.23 copy number variation syndrome WP4932,0.30661838687193077,1.3164004068689044,1.5561845103729248,"['GRIP1', 'SNAP25', 'ATP5MC3', 'DDX21', 'NRG1', 'ATP5F1E', 'ATP5MC1']",0.8840583504106657,0,0,7
142,Farnesoid X receptor pathway WP2879,0.3139014561714962,3.3797333333333333,3.916016495170595,['FKBP5'],0.8840583504106657,0,0,1
143,Glucuronidation WP698,0.3139014561714962,3.3797333333333333,3.916016495170595,['PGM5'],0.8840583504106657,0,0,1
144,"GPCRs, Class B Secretin-like WP334",0.3139014561714962,3.3797333333333333,3.916016495170595,['ADGRE2'],0.8840583504106657,0,0,1
145,PTF1A related regulatory pathway WP4147,0.3139014561714962,3.3797333333333333,3.916016495170595,['RBPJ'],0.8840583504106657,0,0,1
146,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.3139014561714962,3.3797333333333333,3.916016495170595,['STAT3'],0.8840583504106657,0,0,1
147,Thiamine metabolic pathways WP4297,0.3139014561714962,3.3797333333333333,3.916016495170595,['SLC25A19'],0.8840583504106657,0,0,1
148,Prion disease pathway WP3995,0.31655318709479247,1.6020106445890006,1.842735178212763,"['HSPA5', 'STAT3', 'HSP90B1']",0.8840583504106657,0,0,3
149,Type 2 papillary renal cell carcinoma WP4241,0.31655318709479247,1.6020106445890006,1.842735178212763,"['CDKN1A', 'PDGFB', 'ELOB']",0.8840583504106657,0,0,3
150,Interferon type I signaling pathways WP585,0.3247119764411526,1.3715889802846324,1.5427862123931342,"['IFNAR2', 'RPS6KA5', 'RPS6', 'STAT3', 'MAP2K6']",0.8840583504106657,0,0,5
151,Oncostatin M Signaling Pathway WP2374,0.3247119764411526,1.3715889802846324,1.5427862123931342,"['CEBPB', 'RPS6', 'PXN', 'STAT3', 'JAK3']",0.8840583504106657,0,0,5
152,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3286068208960508,1.844114219114219,2.0523023886703995,"['BCL6', 'H2AFZ']",0.8840583504106657,0,0,2
153,Folate Metabolism WP176,0.3286068208960508,1.844114219114219,2.0523023886703995,"['INSR', 'PLAT']",0.8840583504106657,0,0,2
154,IL-9 signaling pathway WP22,0.3286068208960508,1.844114219114219,2.0523023886703995,"['STAT3', 'JAK3']",0.8840583504106657,0,0,2
155,SARS coronavirus and innate immunity WP4912,0.3286068208960508,1.844114219114219,2.0523023886703995,"['IFNAR2', 'IKBKE']",0.8840583504106657,0,0,2
156,DNA damage response (only ATM dependent) WP710,0.33645771731851815,1.2689822294022617,1.3822805059950334,"['CCND3', 'CDKN1A', 'WNT2B', 'MLKL', 'BCL6', 'INSR', 'WNT5A']",0.8848718200546454,0,0,7
157,Aryl Hydrocarbon Receptor Netpath WP2586,0.34209063058292627,1.521669341894061,1.632263623443153,"['CDKN1A', 'HPGDS', 'HSP90AA1']",0.8848718200546454,0,0,3
158,G13 Signaling Pathway WP524,0.3444394367440094,1.3994899656281183,1.4916281927032269,"['ARHGDIG', 'IQGAP1', 'IQGAP2', 'CALM2']",0.8848718200546454,0,0,4
159,Apoptosis Modulation and Signaling WP1772,0.361520756259611,1.3008381848961559,1.3235193679291537,"['CASP4', 'CASP1', 'CYCS', 'TNFRSF1B', 'HSPA1A']",0.8848718200546454,0,0,5
160,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.361520756259611,1.3008381848961559,1.3235193679291537,"['NHSL1', 'TG', 'TBC1D4', 'RPS6', 'MGLL']",0.8848718200546454,0,0,5
161,Cell migration and invasion through p75NTR WP4561,0.3625578532782885,1.6901709401709402,1.71479879644701,"['TIAM1', 'STAT3']",0.8848718200546454,0,0,2
162,Prostaglandin Synthesis and Regulation WP98,0.3625578532782885,1.6901709401709402,1.71479879644701,"['HPGDS', 'S100A6']",0.8848718200546454,0,0,2
163,Notch Signaling Pathway Netpath WP61,0.3655951640052781,1.352625937834941,1.3610509944399127,"['CDKN1A', 'STAT3', 'RBPJ', 'SAP30']",0.8848718200546454,0,0,4
164,Insulin Signaling WP481,0.3661051993639015,1.1633468834688347,1.1689711502002904,"['SNAP25', 'PTPN1', 'XBP1', 'RPS6KA5', 'TBC1D4', 'INSR', 'GAB1', 'ENPP1', 'MAP3K8', 'SGK1', 'MAP2K6']",0.8848718200546454,0,0,11
165,Disruption of postsynaptic signaling by CNV WP4875,0.3675504828311915,1.4489795918367347,1.4502758511751717,"['RYR2', 'DLGAP1', 'GRIN2B']",0.8848718200546454,0,0,3
166,Glycogen Synthesis and Degradation WP500,0.3675504828311915,1.4489795918367347,1.4502758511751717,"['CALM3', 'PYGL', 'CALM2']",0.8848718200546454,0,0,3
167,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.3675504828311915,1.4489795918367347,1.4502758511751717,"['CCND3', 'WNT2B', 'WNT5A']",0.8848718200546454,0,0,3
168,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.3675504828311915,1.4489795918367347,1.4502758511751717,"['CDKN1A', 'HSP90AA1', 'MAP2K6']",0.8848718200546454,0,0,3
169,PPAR signaling pathway WP3942,0.3675504828311915,1.4489795918367347,1.4502758511751717,"['ACSL1', 'OLR1', 'PLTP']",0.8848718200546454,0,0,3
170,Cell Differentiation - Index WP2029,0.3755930746994538,2.5344,2.4818085890240824,['STAT3'],0.8848718200546454,0,0,1
171,Cells and molecules involved in local acute inflammatory response  WP4493,0.3755930746994538,2.5344,2.4818085890240824,['SELPLG'],0.8848718200546454,0,0,1
172,GDNF/RET signaling axis WP4830,0.3755930746994538,2.5344,2.4818085890240824,['ROBO2'],0.8848718200546454,0,0,1
173,Hedgehog Signaling Pathway Netpath WP47,0.3755930746994538,2.5344,2.4818085890240824,['ARNTL'],0.8848718200546454,0,0,1
174,HIF1A and PPARG regulation of glycolysis WP2456,0.3755930746994538,2.5344,2.4818085890240824,['TPI1'],0.8848718200546454,0,0,1
175,NAD+ metabolism WP3644,0.3755930746994538,2.5344,2.4818085890240824,['NAMPT'],0.8848718200546454,0,0,1
176,NOTCH1 regulation of endothelial cell calcification WP3413,0.3755930746994538,2.5344,2.4818085890240824,['PLAT'],0.8848718200546454,0,0,1
177,SARS-CoV-2 and COVID-19 Pathway WP4846,0.3755930746994538,2.5344,2.4818085890240824,['CTSL'],0.8848718200546454,0,0,1
178,Ras signaling WP4223,0.3855466454840886,1.1533353010625738,1.0992359097478703,"['TIAM1', 'GNG10', 'GNG3', 'INSR', 'GAB1', 'CALM3', 'KSR2', 'GRIN2B', 'CALM2', 'RASGRP3']",0.8874448289278019,0,0,10
179,IL-4 signaling pathway WP395,0.3867162377256176,1.3087853957058397,1.243430006961231,"['CEBPB', 'IL4R', 'STAT3', 'JAK3']",0.8874448289278019,0,0,4
180,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.3867162377256176,1.3087853957058397,1.243430006961231,"['KIRREL3', 'CDKN1A', 'CTSL', 'TLR4']",0.8874448289278019,0,0,4
181,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3867162377256176,1.3087853957058397,1.243430006961231,"['ANGPT2', 'STMN1', 'PXN', 'STAT3']",0.8874448289278019,0,0,4
182,Senescence and Autophagy in Cancer WP615,0.38983275740062207,1.2174193548387098,1.1468546355806413,"['GABARAPL1', 'CDKN1A', 'CEBPB', 'MAP1LC3A', 'PLAT', 'IGF1']",0.8874448289278019,0,0,6
183,G1 to S cell cycle control WP45,0.3928322943045611,1.382898000875529,1.2921418488237324,"['CDKN1A', 'CCND3', 'TFDP2']",0.8874448289278019,0,0,3
184,Metabolic reprogramming in colon cancer WP4290,0.3928322943045611,1.382898000875529,1.2921418488237324,"['PGAM1', 'SLC1A5', 'SLC16A3']",0.8874448289278019,0,0,3
185,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.3958387006728325,1.5599112426035502,1.4456453609110567,"['RPS6', 'SGK1']",0.8874448289278019,0,0,2
186,Nuclear receptors WP170,0.3958387006728325,1.5599112426035502,1.4456453609110567,"['ESRRA', 'RORA']",0.8874448289278019,0,0,2
187,Alzheimer's disease WP2059,0.41681739200140583,1.2073460624185262,1.05655706545562,"['ATP5MD', 'CYCS', 'CALM3', 'GRIN2B', 'CALM2']",0.8928982746307562,0,0,5
188,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.41681739200140583,1.2073460624185262,1.05655706545562,"['HSPA5', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.8928982746307562,0,0,5
189,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.42829568311529825,1.4482600732600732,1.2280397805690426,"['PTPN1', 'CEBPB']",0.8928982746307562,0,0,2
190,Exercise-induced Circadian Regulation WP410,0.4286250035136335,1.2290753191074735,1.0412392532456565,"['PER2', 'CEBPB', 'ERC2', 'ARNTL']",0.8928982746307562,0,0,4
191,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.4286250035136335,1.2290753191074735,1.0412392532456565,"['RPS6KA5', 'IRAK2', 'MAP3K8', 'MAP2K6']",0.8928982746307562,0,0,4
192,Cytokines and Inflammatory Response WP530,0.4317456508658764,2.0272,1.7026830574307452,['IL15'],0.8928982746307562,0,0,1
193,Fatty acid transporters WP5061,0.4317456508658764,2.0272,1.7026830574307452,['ACSL1'],0.8928982746307562,0,0,1
194,FOXP3 in COVID-19 WP5063,0.4317456508658764,2.0272,1.7026830574307452,['STAT3'],0.8928982746307562,0,0,1
195,Glial Cell Differentiation WP2276,0.4317456508658764,2.0272,1.7026830574307452,['GAP43'],0.8928982746307562,0,0,1
196,LDLRAD4 and what we know about it WP4904,0.4317456508658764,2.0272,1.7026830574307452,['PMEPA1'],0.8928982746307562,0,0,1
197,Osteoclast Signaling WP12,0.4317456508658764,2.0272,1.7026830574307452,['PDGFB'],0.8928982746307562,0,0,1
198,Selective expression of chemokine receptors during T-cell polarization WP4494,0.4317456508658764,2.0272,1.7026830574307452,['IL4R'],0.8928982746307562,0,0,1
199,Urea cycle and metabolism of amino groups WP497,0.4317456508658764,2.0272,1.7026830574307452,['SRM'],0.8928982746307562,0,0,1
200,Vitamin A and carotenoid metabolism WP716,0.4317456508658764,2.0272,1.7026830574307452,['BCO2'],0.8928982746307562,0,0,1
201,Vitamin D Receptor Pathway WP2877,0.43511306460836074,1.1790810021345917,0.9811715048829959,"['CDKN1A', 'DUSP10', 'BCL6', 'S100A6', 'CD14']",0.8928982746307562,0,0,5
202,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.4425115808330001,1.267255216693419,1.0331787865895783,"['XBP1', 'MAP1LC3A', 'HSPA5']",0.8928982746307562,0,0,3
203,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.4425115808330001,1.267255216693419,1.0331787865895783,"['IFNAR2', 'OAS1', 'IKBKE']",0.8928982746307562,0,0,3
204,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.4576090120942123,1.1089458804523424,0.8669075132141288,"['RYR2', 'SNAP25', 'CEBPB', 'BHLHE40', 'RORA', 'HSP90B1', 'YWHAH']",0.8928982746307562,0,0,7
205,Neovascularisation processes WP4331,0.4598080655240199,1.3514957264957266,1.0500393682392337,"['CXCL12', 'PDGFB']",0.8928982746307562,0,0,2
206,Physiological and pathological hypertrophy of the heart WP1528,0.4598080655240199,1.3514957264957266,1.0500393682392337,"['STAT3', 'CALM2']",0.8928982746307562,0,0,2
207,3q29 copy number variation syndrome WP4906,0.4697484195488019,1.1584749655489206,0.875295033981663,"['PXN', 'SLC40A1', 'DYNLL1', 'HAMP']",0.8928982746307562,0,0,4
208,Synaptic Vesicle Pathway WP2267,0.4697484195488019,1.1584749655489206,0.875295033981663,"['SNAP25', 'RAB3A', 'CACNA1B', 'SYN3']",0.8928982746307562,0,0,4
209,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.47128648970654474,1.1263195562712471,0.8473179382293633,"['CCND3', 'APEX1', 'RPS6', 'STAT3', 'MAP2K6']",0.8928982746307562,0,0,5
210,Androgen receptor signaling pathway WP138,0.47212824889833094,1.1058651026392963,0.8299568647973268,"['CDKN1A', 'LIMK2', 'STAT3', 'DSTN', 'STUB1', 'CALR']",0.8928982746307562,0,0,6
211,Cell Differentiation - Index expanded WP2023,0.4828557877637125,1.6890666666666667,1.2297034442611408,['STAT3'],0.8928982746307562,0,0,1
212,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.4828557877637125,1.6890666666666667,1.2297034442611408,['STAT3'],0.8928982746307562,0,0,1
213,Differentiation of white and brown adipocyte WP2895,0.4828557877637125,1.6890666666666667,1.2297034442611408,['CEBPB'],0.8928982746307562,0,0,1
214,Estrogen Receptor Pathway WP2881,0.4828557877637125,1.6890666666666667,1.2297034442611408,['STAT3'],0.8928982746307562,0,0,1
215,Galanin receptor pathway WP4970,0.4828557877637125,1.6890666666666667,1.2297034442611408,['CDKN1A'],0.8928982746307562,0,0,1
216,Nanomaterial induced apoptosis WP2507,0.4828557877637125,1.6890666666666667,1.2297034442611408,['CYCS'],0.8928982746307562,0,0,1
217,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4828557877637125,1.6890666666666667,1.2297034442611408,['ANAPC11'],0.8928982746307562,0,0,1
218,Hippo-Merlin Signaling Dysregulation WP4541,0.48910098389639894,1.1016593152699012,0.7878916493194377,"['INSR', 'ITGAX', 'CDH12', 'CDH8', 'CDH18']",0.8928982746307562,0,0,5
219,Aryl Hydrocarbon Receptor Pathway WP2873,0.4902833930538337,1.2668269230769231,0.9029583819592211,"['SLC7A5', 'HSP90AA1']",0.8928982746307562,0,0,2
220,IL-7 signaling pathway WP205,0.4902833930538337,1.2668269230769231,0.9029583819592211,"['STAT3', 'JAK3']",0.8928982746307562,0,0,2
221,TLR4 Signaling and Tolerance WP3851,0.4902833930538337,1.2668269230769231,0.9029583819592211,"['IKBKE', 'TLR4']",0.8928982746307562,0,0,2
222,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.4905262518738205,1.1694036300777875,0.8329387022304175,"['CCND3', 'WNT2B', 'WNT5A']",0.8928982746307562,0,0,3
223,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4905262518738205,1.1694036300777875,0.8329387022304175,"['PXN', 'STAT3', 'GAB1']",0.8928982746307562,0,0,3
224,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.4905262518738205,1.1694036300777875,0.8329387022304175,"['CDKN1A', 'CEBPB', 'CEBPD']",0.8928982746307562,0,0,3
225,TNF-alpha signaling pathway WP231,0.5042493252408142,1.066723259762309,0.730368818057729,"['HSP90AA1', 'MAP3K8', 'PYGL', 'KSR2', 'TNFRSF1B', 'MAP2K6']",0.8928982746307562,0,0,6
226,Common Pathways Underlying Drug Addiction WP2636,0.5137617114405221,1.1259140360263955,0.7498539261994283,"['GRM5', 'CALM2', 'ACTG1']",0.8928982746307562,0,0,3
227,PDGF Pathway WP2526,0.5137617114405221,1.1259140360263955,0.7498539261994283,"['TIAM1', 'STAT3', 'PDGFB']",0.8928982746307562,0,0,3
228,Chemokine signaling pathway WP3929,0.514068060449224,1.0392498547838354,0.6915164469926993,"['CX3CR1', 'TIAM1', 'GNG10', 'GNG3', 'CXCL12', 'PXN', 'STAT3', 'JAK3']",0.8928982746307562,0,0,8
229,Nanoparticle triggered autophagic cell death WP2509,0.5196533967076447,1.1921191553544495,0.7803531337406301,"['MAP1LC3A', 'INSR']",0.8928982746307562,0,0,2
230,Signal transduction through IL1R WP4496,0.5196533967076447,1.1921191553544495,0.7803531337406301,"['IRAK2', 'MAP2K6']",0.8928982746307562,0,0,2
231,The influence of laminopathies on Wnt signaling WP4844,0.5196533967076447,1.1921191553544495,0.7803531337406301,"['CEBPB', 'CEBPD']",0.8928982746307562,0,0,2
232,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5293756306753488,1.4475428571428572,0.9207197992474182,['RYR2'],0.8928982746307562,0,0,1
233,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5293756306753488,1.4475428571428572,0.9207197992474182,['RAB27A'],0.8928982746307562,0,0,1
234,ERK Pathway in Huntington's Disease WP3853,0.5293756306753488,1.4475428571428572,0.9207197992474182,['RPS6KA5'],0.8928982746307562,0,0,1
235,Globo Sphingolipid Metabolism WP1424,0.5293756306753488,1.4475428571428572,0.9207197992474182,['ST6GALNAC5'],0.8928982746307562,0,0,1
236,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.5293756306753488,1.4475428571428572,0.9207197992474182,['ELOB'],0.8928982746307562,0,0,1
237,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5293756306753488,1.4475428571428572,0.9207197992474182,['NRG3'],0.8928982746307562,0,0,1
238,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5293756306753488,1.4475428571428572,0.9207197992474182,['UGCG'],0.8928982746307562,0,0,1
239,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.5293756306753488,1.4475428571428572,0.9207197992474182,['ACSL1'],0.8928982746307562,0,0,1
240,"NAD metabolism, sirtuins and aging WP3630",0.5293756306753488,1.4475428571428572,0.9207197992474182,['NAMPT'],0.8928982746307562,0,0,1
241,NAD+ biosynthetic pathways WP3645,0.5293756306753488,1.4475428571428572,0.9207197992474182,['NAMPT'],0.8928982746307562,0,0,1
242,Neuroinflammation WP4919,0.5293756306753488,1.4475428571428572,0.9207197992474182,['TLR4'],0.8928982746307562,0,0,1
243,Omega-3/Omega-6 FA synthesis WP4723,0.5293756306753488,1.4475428571428572,0.9207197992474182,['ACSL1'],0.8928982746307562,0,0,1
244,Ovarian infertility WP34,0.5293756306753488,1.4475428571428572,0.9207197992474182,['CEBPB'],0.8928982746307562,0,0,1
245,RalA downstream regulated genes WP2290,0.5293756306753488,1.4475428571428572,0.9207197992474182,['YBX3'],0.8928982746307562,0,0,1
246,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.5293756306753488,1.4475428571428572,0.9207197992474182,['STAT3'],0.8928982746307562,0,0,1
247,Cytosolic DNA-sensing pathway WP4655,0.536420734519231,1.0855308415501033,0.6761082010790789,"['CASP1', 'TMEM173', 'IKBKE']",0.8928982746307562,0,0,3
248,IL-2 signaling pathway WP49,0.536420734519231,1.0855308415501033,0.6761082010790789,"['STAT3', 'RPS6', 'JAK3']",0.8928982746307562,0,0,3
249,Glycerophospholipid Biosynthetic Pathway WP2533,0.5478704046295622,1.1257122507122508,0.6773596444033881,"['PGS1', 'GK']",0.8928982746307562,0,0,2
250,Parkinson's disease pathway WP2371,0.5478704046295622,1.1257122507122508,0.6773596444033881,"['LRRK2', 'CYCS']",0.8928982746307562,0,0,2
251,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5478704046295622,1.1257122507122508,0.6773596444033881,"['CALM3', 'CALM2']",0.8928982746307562,0,0,2
252,Cell cycle WP179,0.5579124046639178,1.0128824476650564,0.5910709047860837,"['CCND3', 'CDKN1A', 'TFDP2', 'ANAPC11', 'YWHAH']",0.8928982746307562,0,0,5
253,Metapathway biotransformation Phase I and II WP702,0.5584665102345978,1.0479326949687275,0.6104843268293161,"['SULT4A1', 'HS3ST4', 'GAL3ST4']",0.8928982746307562,0,0,3
254,Ebola Virus Pathway on Host WP4217,0.559620287604121,0.9984982593460602,0.5796250274692736,"['TIAM1', 'SCIN', 'CTSL', 'IQGAP1', 'IKBKE', 'TLR4', 'ACTG1']",0.8928982746307562,0,0,7
255,Computational Model of Aerobic Glycolysis WP4629,0.5717168410990924,1.2664,0.7080587316877207,['TPI1'],0.8928982746307562,0,0,1
256,Omega-9 FA synthesis WP4724,0.5717168410990924,1.2664,0.7080587316877207,['ACSL1'],0.8928982746307562,0,0,1
257,Peptide GPCRs WP24,0.5717168410990924,1.2664,0.7080587316877207,['CX3CR1'],0.8928982746307562,0,0,1
258,PPAR-alpha pathway WP2878,0.5717168410990924,1.2664,0.7080587316877207,['PLTP'],0.8928982746307562,0,0,1
259,Purine metabolism and related disorders WP4224,0.5717168410990924,1.2664,0.7080587316877207,['GRM5'],0.8928982746307562,0,0,1
260,TP53 network WP1742,0.5717168410990924,1.2664,0.7080587316877207,['CDKN1A'],0.8928982746307562,0,0,1
261,Triacylglyceride synthesis WP325,0.5717168410990924,1.2664,0.7080587316877207,['GK'],0.8928982746307562,0,0,1
262,DNA damage response WP707,0.579869203710688,1.0128410914927768,0.5519504993470983,"['CDKN1A', 'CCND3', 'CYCS']",0.8928982746307562,0,0,3
263,miRNA regulation of DNA damage response WP1530,0.579869203710688,1.0128410914927768,0.5519504993470983,"['CDKN1A', 'CCND3', 'CYCS']",0.8928982746307562,0,0,3
264,Regulation of Microtubule Cytoskeleton WP2038,0.579869203710688,1.0128410914927768,0.5519504993470983,"['TIAM1', 'STMN1', 'STAT3']",0.8928982746307562,0,0,3
265,Wnt signaling pathway and pluripotency WP399,0.585224115754312,0.9880009411026586,0.5293317806526904,"['CCND3', 'WNT2B', 'LRRK2', 'WNT5A']",0.8928982746307562,0,0,4
266,Breast cancer pathway WP4262,0.5905419218043433,0.9736157562244518,0.5128176843414066,"['CDKN1A', 'WNT2B', 'WNT5A', 'FGF20', 'IGF1']",0.8928982746307562,0,0,5
267,Hepatitis B infection WP4666,0.5929123278187749,0.964093080597935,0.5039398756197864,"['CDKN1A', 'STAT3', 'CYCS', 'IKBKE', 'JAK3', 'TLR4', 'MAP2K6', 'TLR2']",0.8928982746307562,0,0,8
268,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6006053866559083,0.9800134624346295,0.4996276749685468,"['CXCL12', 'TMEM173', 'IKBKE']",0.8928982746307562,0,0,3
269,Hematopoietic Stem Cell Differentiation WP2849,0.6007392840661097,1.0128205128205128,0.5161275016318033,"['PIM1', 'RUNX1']",0.8928982746307562,0,0,2
270,Head and Neck Squamous Cell Carcinoma WP4674,0.6030141788373978,0.9643239932629,0.48776912474402867,"['CDKN1A', 'RPS6', 'DDIT4', 'GAB1']",0.8928982746307562,0,0,4
271,Non-small cell lung cancer WP4255,0.6030141788373978,0.9643239932629,0.48776912474402867,"['CDKN1A', 'STAT3', 'CYCS', 'JAK3']",0.8928982746307562,0,0,4
272,Airway smooth muscle cell contraction WP4962,0.6102542164742578,1.1255111111111111,0.5558670452326963,['CALM2'],0.8928982746307562,0,0,1
273,Autosomal recessive Osteopetrosis pathways WP4788,0.6102542164742578,1.1255111111111111,0.5558670452326963,['TCIRG1'],0.8928982746307562,0,0,1
274,Cancer immunotherapy by PD-1 blockade WP4585,0.6102542164742578,1.1255111111111111,0.5558670452326963,['STAT3'],0.8928982746307562,0,0,1
275,Canonical and non-canonical Notch signaling WP3845,0.6102542164742578,1.1255111111111111,0.5558670452326963,['RBPJ'],0.8928982746307562,0,0,1
276,Constitutive Androstane Receptor Pathway WP2875,0.6102542164742578,1.1255111111111111,0.5558670452326963,['HSP90AA1'],0.8928982746307562,0,0,1
277,Eicosanoid Synthesis WP167,0.6102542164742578,1.1255111111111111,0.5558670452326963,['LTC4S'],0.8928982746307562,0,0,1
278,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6102542164742578,1.1255111111111111,0.5558670452326963,['WNT5A'],0.8928982746307562,0,0,1
279,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.6102542164742578,1.1255111111111111,0.5558670452326963,['MAP2K6'],0.8928982746307562,0,0,1
280,Methionine De Novo and Salvage Pathway WP3580,0.6102542164742578,1.1255111111111111,0.5558670452326963,['SRM'],0.8928982746307562,0,0,1
281,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6102542164742578,1.1255111111111111,0.5558670452326963,['HMOX1'],0.8928982746307562,0,0,1
282,Pregnane X receptor pathway WP2876,0.6102542164742578,1.1255111111111111,0.5558670452326963,['HSP90AA1'],0.8928982746307562,0,0,1
283,Sleep regulation WP3591,0.6102542164742578,1.1255111111111111,0.5558670452326963,['PER3'],0.8928982746307562,0,0,1
284,Tryptophan metabolism WP465,0.6102542164742578,1.1255111111111111,0.5558670452326963,['KYNU'],0.8928982746307562,0,0,1
285,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6102542164742578,1.1255111111111111,0.5558670452326963,['ZBTB16'],0.8928982746307562,0,0,1
286,Integrated Cancer Pathway WP1971,0.6253724696429563,0.9644383394383395,0.4527149325094735,"['CDKN1A', 'BACH1']",0.9054872216705305,0,0,2
287,Neural Crest Differentiation WP2064,0.6253724696429563,0.9644383394383395,0.4527149325094735,"['HDAC4', 'RBPJ']",0.9054872216705305,0,0,2
288,Vitamin D-sensitive calcium signaling in depression WP4698,0.6253724696429563,0.9644383394383395,0.4527149325094735,"['GRM5', 'GRIN2B']",0.9054872216705305,0,0,2
289,Circadian rhythm related genes WP3594,0.6299039151737444,0.9304021128594279,0.4300206794806684,"['PER2', 'PER3', 'KCNH7', 'NAMPT', 'BHLHE40', 'RORA', 'RPS27A', 'ARNTL']",0.9078996930530187,0,0,8
290,Pathways Regulating Hippo Signaling WP4540,0.6371731242252259,0.9201987722888044,0.41474635881076505,"['INSR', 'CDH12', 'CDH8', 'CDH18']",0.9078996930530187,0,0,4
291,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6400132098842793,0.9203268641470889,0.41071101391207043,"['CDKN1A', 'TMSB4X', 'PFN2']",0.9078996930530187,0,0,3
292,Modulators of TCR signaling and T cell activation WP5072,0.6400132098842793,0.9203268641470889,0.41071101391207043,"['NDUFB10', 'ELOB', 'MAP3K8']",0.9078996930530187,0,0,3
293,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6400132098842793,0.9203268641470889,0.41071101391207043,"['IFI27L2', 'TLR4', 'TLR2']",0.9078996930530187,0,0,3
294,Angiogenesis WP1539,0.6453289862306021,1.0128,0.44360137251075404,['PDGFB'],0.9078996930530187,0,0,1
295,Imatinib and Chronic Myeloid Leukemia WP3640,0.6453289862306021,1.0128,0.44360137251075404,['PIM1'],0.9078996930530187,0,0,1
296,Mitochondrial Gene Expression WP391,0.6453289862306021,1.0128,0.44360137251075404,['ESRRA'],0.9078996930530187,0,0,1
297,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6488108118220612,0.9204545454545454,0.39820162580202784,"['CDKN1A', 'STAT3']",0.9078996930530187,0,0,2
298,Neural Crest Cell Migration during Development WP4564,0.6488108118220612,0.9204545454545454,0.39820162580202784,"['TIAM1', 'STAT3']",0.9078996930530187,0,0,2
299,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6710697924730581,0.8802954292084727,0.35113412005021444,"['MAP1LC3A', 'IGF1']",0.9169285922913382,0,0,2
300,Glycolysis and Gluconeogenesis WP534,0.6710697924730581,0.8802954292084727,0.35113412005021444,"['TPI1', 'PGAM1']",0.9169285922913382,0,0,2
301,p38 MAPK Signaling Pathway WP400,0.6710697924730581,0.8802954292084727,0.35113412005021444,"['RPS6KA5', 'MAP2K6']",0.9169285922913382,0,0,2
302,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.6772518139705807,0.9205818181818182,0.3587618916148795,['MAP2K6'],0.9169285922913382,0,0,1
303,Ebstein-Barr virus LMP1 signaling WP262,0.6772518139705807,0.9205818181818182,0.3587618916148795,['HSP90AA1'],0.9169285922913382,0,0,1
304,Endothelin Pathways WP2197,0.6772518139705807,0.9205818181818182,0.3587618916148795,['CALM2'],0.9169285922913382,0,0,1
305,Fatty Acid Biosynthesis WP357,0.6772518139705807,0.9205818181818182,0.3587618916148795,['ACSL1'],0.9169285922913382,0,0,1
306,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6772518139705807,0.9205818181818182,0.3587618916148795,['CDKN1A'],0.9169285922913382,0,0,1
307,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6772518139705807,0.9205818181818182,0.3587618916148795,['RPS6'],0.9169285922913382,0,0,1
308,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6772518139705807,0.9205818181818182,0.3587618916148795,['PXN'],0.9169285922913382,0,0,1
309,Amyotrophic lateral sclerosis (ALS) WP2447,0.6921717541859006,0.843482905982906,0.31033520454520036,"['CASP1', 'MAP2K6']",0.9280888150981368,0,0,2
310,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6921717541859006,0.843482905982906,0.31033520454520036,"['CYCS', 'ACTG1']",0.9280888150981368,0,0,2
311,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6921717541859006,0.843482905982906,0.31033520454520036,"['IFITM3', 'MAP2K6']",0.9280888150981368,0,0,2
312,Prolactin Signaling Pathway WP2037,0.6995413544007059,0.8429796355841372,0.30122222228729767,"['PTPN1', 'RPS6', 'PXN', 'STAT3']",0.9320550840333135,0,0,4
313,Heart Development WP1591,0.7063055313058203,0.8437333333333333,0.2933722993397311,['BHLHE40'],0.9320550840333135,0,0,1
314,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7063055313058203,0.8437333333333333,0.2933722993397311,['NAMPT'],0.9320550840333135,0,0,1
315,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.7063055313058203,0.8437333333333333,0.2933722993397311,['RPS6KA5'],0.9320550840333135,0,0,1
316,Sphingolipid Metabolism (general overview) WP4725,0.7063055313058203,0.8437333333333333,0.2933722993397311,['UGCG'],0.9320550840333135,0,0,1
317,Neural Crest Cell Migration in Cancer WP4565,0.7121445461141397,0.8096153846153846,0.2748436758483869,"['TIAM1', 'STAT3']",0.9338499236779757,0,0,2
318,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7121445461141397,0.8096153846153846,0.2748436758483869,"['STAT3', 'RPS6']",0.9338499236779757,0,0,2
319,Melanoma WP4685,0.7262250933814253,0.7985976176396047,0.25546759750685366,"['CDKN1A', 'CALM3', 'CALM2']",0.9372876096766357,0,0,3
320,Osteoblast differentiation WP4787,0.7262250933814253,0.7985976176396047,0.25546759750685366,"['WNT2B', 'WNT5A', 'RBPJ']",0.9372876096766357,0,0,3
321,Thermogenesis WP4321,0.7276870993842135,0.8090032154340836,0.2571692846951595,"['ACSL1', 'RPS6', 'MGLL', 'ACTG1']",0.9372876096766357,0,0,4
322,Ethanol effects on histone modifications WP3996,0.7327476277088327,0.7787076923076923,0.24214222262842905,['HDAC4'],0.9372876096766357,0,0,1
323,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7327476277088327,0.7787076923076923,0.24214222262842905,['ANGPT2'],0.9372876096766357,0,0,1
324,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7327476277088327,0.7787076923076923,0.24214222262842905,['RAB27A'],0.9372876096766357,0,0,1
325,MTHFR deficiency WP4288,0.7327476277088327,0.7787076923076923,0.24214222262842905,['CYCS'],0.9372876096766357,0,0,1
326,Sphingolipid Metabolism (integrated pathway) WP4726,0.7327476277088327,0.7787076923076923,0.24214222262842905,['UGCG'],0.9372876096766357,0,0,1
327,AGE/RAGE pathway WP2324,0.7413799178607158,0.7779972836152611,0.2328095218148296,"['INSR', 'STAT3', 'CYCS']",0.945429436537977,0,0,3
328,Overview of interferons-mediated signaling pathway WP4558,0.7568125179881525,0.7229714285714286,0.20144855693067656,['IFNAR2'],0.9517528904472591,0,0,1
329,Interleukin-11 Signaling Pathway WP2332,0.7656256176615688,0.7225274725274725,0.1929596163393762,"['STAT3', 'RPS6']",0.9517528904472591,0,0,2
330,Microglia Pathogen Phagocytosis Pathway WP3937,0.7656256176615688,0.7225274725274725,0.1929596163393762,"['C1QB', 'FCER1G']",0.9517528904472591,0,0,2
331,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7656256176615688,0.7225274725274725,0.1929596163393762,"['IFNAR2', 'CXCL12']",0.9517528904472591,0,0,2
332,Kit receptor signaling pathway WP304,0.7696812062065735,0.7398112985945269,0.1936669641147279,"['RPS6', 'STAT3', 'SOCS6']",0.9517528904472591,0,0,3
333,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7779781826431296,0.7486006907228773,0.18794129244745472,"['WNT2B', 'WNT5A', 'RBPJ', 'MAP2K6']",0.9517528904472591,0,0,4
334,16p11.2 distal deletion syndrome WP4950,0.7787136069285208,0.6746666666666666,0.1687421906402126,['INSR'],0.9517528904472591,0,0,1
335,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7787136069285208,0.6746666666666666,0.1687421906402126,['WNT5A'],0.9517528904472591,0,0,1
336,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.7787136069285208,0.6746666666666666,0.1687421906402126,['MAP1LC3A'],0.9517528904472591,0,0,1
337,miRNAs involvement in the immune response in sepsis WP4329,0.7787136069285208,0.6746666666666666,0.1687421906402126,['TLR4'],0.9517528904472591,0,0,1
338,Oxidative Stress WP408,0.7787136069285208,0.6746666666666666,0.1687421906402126,['HMOX1'],0.9517528904472591,0,0,1
339,Sphingolipid pathway WP1422,0.7787136069285208,0.6746666666666666,0.1687421906402126,['UGCG'],0.9517528904472591,0,0,1
340,Vitamin D in inflammatory diseases WP4482,0.7787136069285208,0.6746666666666666,0.1687421906402126,['MAP2K6'],0.9517528904472591,0,0,1
341,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7814328276297733,0.6975022104332449,0.17202224009621384,"['RYR2', 'ACTG1']",0.9517528904472591,0,0,2
342,IL-6 signaling pathway WP364,0.7814328276297733,0.6975022104332449,0.17202224009621384,"['STAT3', 'GAB1']",0.9517528904472591,0,0,2
343,Male infertility WP4673,0.7828566940609349,0.7220820912634717,0.17676975503578882,"['POLB', 'INSR', 'ARNTL']",0.9517528904472591,0,0,3
344,ErbB signaling pathway WP673,0.7893362781896643,0.734872844197603,0.17384360767860135,"['CDKN1A', 'NRG3', 'GAB1', 'NRG1']",0.9540673275509856,0,0,4
345,G Protein Signaling Pathways WP35,0.7893362781896643,0.734872844197603,0.17384360767860135,"['GNG10', 'GNG3', 'PDE4B', 'CALM2']",0.9540673275509856,0,0,4
346,IL-5 signaling pathway WP127,0.7962972251017835,0.6741452991452992,0.1535586798900645,"['STAT3', 'RPS6']",0.9542551166714245,0,0,2
347,Alpha 6 Beta 4 signaling pathway WP244,0.7986451695883144,0.6324,0.14218788320079342,['GAB1'],0.9542551166714245,0,0,1
348,Intraflagellar transport proteins binding to dynein WP4532,0.7986451695883144,0.6324,0.14218788320079342,['DYNLL1'],0.9542551166714245,0,0,1
349,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7986451695883144,0.6324,0.14218788320079342,['CALM2'],0.9542551166714245,0,0,1
350,Wnt signaling WP428,0.8073403332194296,0.6890412957828688,0.147461709241189,"['CCND3', 'WNT2B', 'WNT5A']",0.9589650544389575,0,0,3
351,Splicing factor NOVA regulated synaptic proteins WP4148,0.8102602993774034,0.6522952853598015,0.13724274910452683,"['EPB41L3', 'GRIN2B']",0.9589650544389575,0,0,2
352,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8102602993774034,0.6522952853598015,0.13724274910452683,"['ADAMTSL2', 'STAT3']",0.9589650544389575,0,0,2
353,EPO Receptor Signaling WP581,0.8167840637112548,0.5951058823529412,0.12043783968689822,['STAT3'],0.9589650544389575,0,0,1
354,Eukaryotic Transcription Initiation WP405,0.8167840637112548,0.5951058823529412,0.12043783968689822,['POLR2I'],0.9589650544389575,0,0,1
355,Nanoparticle-mediated activation of receptor signaling WP2643,0.8167840637112548,0.5951058823529412,0.12043783968689822,['PXN'],0.9589650544389575,0,0,1
356,Pathways in clear cell renal cell carcinoma WP4018,0.8186847946769038,0.6736222578919208,0.13476226556146728,"['TPI1', 'STAT3', 'PDGFB']",0.9589650544389575,0,0,3
357,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8226361394741974,0.7433891675877902,0.14514026073713926,"['GRIP1', 'TIAM1', 'RAB3A', 'RPS6KA5', 'RPS6', 'STAT3', 'GRIN2B']",0.9608943141757433,0,0,7
358,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.833291288993552,0.5619555555555555,0.10248496491354464,['RAB3A'],0.9625553116629119,0,0,1
359,Notch Signaling WP268,0.833291288993552,0.5619555555555555,0.10248496491354464,['RBPJ'],0.9625553116629119,0,0,1
360,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.833291288993552,0.5619555555555555,0.10248496491354464,['ANGPT2'],0.9625553116629119,0,0,1
361,Type II interferon signaling (IFNG) WP619,0.833291288993552,0.5619555555555555,0.10248496491354464,['OAS1'],0.9625553116629119,0,0,1
362,Glioblastoma signaling pathways WP2261,0.8396750046516835,0.6447525699258905,0.11266429697525782,"['CDKN1A', 'GAB1', 'MAP2K6']",0.9665210126239057,0,0,3
363,AMP-activated protein kinase (AMPK) signaling WP1403,0.8471568672822428,0.5944570135746606,0.09860222702322873,"['CDKN1A', 'INSR']",0.9665210126239057,0,0,2
364,Gastrin signaling pathway WP4659,0.8480016224238349,0.6619577249486057,0.1091387772280109,"['CDKN1A', 'RPS6', 'PXN', 'STAT3']",0.9665210126239057,0,0,4
365,ATM Signaling Pathway WP2516,0.8483134067634279,0.5322947368421053,0.08756521382961271,['CDKN1A'],0.9665210126239057,0,0,1
366,Nephrotic syndrome WP4758,0.8483134067634279,0.5322947368421053,0.08756521382961271,['YARS'],0.9665210126239057,0,0,1
367,EGF/EGFR signaling pathway WP437,0.8567765839219718,0.7198335644937587,0.11127049745372986,"['NDUFA13', 'PLSCR1', 'RPS6KA5', 'LIMK2', 'STMN1', 'STAT3', 'GAB1', 'IQGAP1']",0.969528165817168,0,0,8
368,Rett syndrome causing genes WP4312,0.8579278014065588,0.5773809523809523,0.08847516110844873,"['CECR2', 'GRIN2B']",0.969528165817168,0,0,2
369,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8579278014065588,0.5773809523809523,0.08847516110844873,"['MAP3K8', 'CALM2']",0.969528165817168,0,0,2
370,Translation Factors WP107,0.8680009914679305,0.5612535612535613,0.07945241353111422,"['EIF4A2', 'EEF1B2']",0.9755904856870623,0,0,2
371,miRNA regulation of prostate cancer signaling pathways WP3981,0.8744240155745492,0.48144761904761907,0.06460539692289811,['CDKN1A'],0.9755904856870623,0,0,1
372,DNA IR-damage and cellular response via ATR WP4016,0.8774146215135256,0.545997920997921,0.0714032198019824,"['POLB', 'BCL6']",0.9755904856870623,0,0,2
373,Small cell lung cancer WP4658,0.8774146215135256,0.545997920997921,0.0714032198019824,"['CDKN1A', 'CYCS']",0.9755904856870623,0,0,2
374,Leptin signaling pathway WP2034,0.8831751944654826,0.582294110383998,0.07233938131123925,"['PTPN1', 'RPS6', 'STAT3']",0.9755904856870623,0,0,3
375,Pancreatic adenocarcinoma pathway WP4263,0.8831751944654826,0.582294110383998,0.07233938131123925,"['TIAM1', 'CDKN1A', 'STAT3']",0.9755904856870623,0,0,3
376,Integrin-mediated Cell Adhesion WP185,0.8904972216406164,0.5712165722765681,0.0662470111964521,"['PXN', 'ITGAX', 'MAP2K6']",0.9755904856870623,0,0,3
377,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8906006593975725,0.6300322061191627,0.07299499316306915,"['PTPN1', 'RPS6KA5', 'INSR', 'MAP3K8', 'MAP2K6']",0.9755904856870623,0,0,5
378,Amino Acid metabolism WP3925,0.8944097667244592,0.5178336620644313,0.05778570915226809,"['IARS', 'SRM']",0.9755904856870623,0,0,2
379,BDNF-TrkB Signaling WP3676,0.8960459376933929,0.43944347826086955,0.04823489710450523,['GAB1'],0.9755904856870623,0,0,1
380,MAPK Cascade WP422,0.8960459376933929,0.43944347826086955,0.04823489710450523,['MAP2K6'],0.9755904856870623,0,0,1
381,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8960459376933929,0.43944347826086955,0.04823489710450523,['STAT3'],0.9755904856870623,0,0,1
382,PDGFR-beta pathway WP3972,0.8960459376933929,0.43944347826086955,0.04823489710450523,['STAT3'],0.9755904856870623,0,0,1
383,Target Of Rapamycin (TOR) Signaling WP1471,0.8960459376933929,0.43944347826086955,0.04823489710450523,['DDIT4'],0.9755904856870623,0,0,1
384,Fragile X Syndrome  WP4549,0.9018678812407189,0.6144691881701426,0.06346682821526545,"['GRIP1', 'GRM5', 'GAB1', 'GRIN2B', 'HCN1']",0.97703775314645,0,0,5
385,IL-1 signaling pathway WP195,0.9020612349193843,0.5048076923076923,0.05203197930331254,"['IRAK2', 'MAP2K6']",0.97703775314645,0,0,2
386,B Cell Receptor Signaling Pathway WP23,0.909805905488054,0.5760220486908589,0.05444790403689641,"['BCL6', 'GAB1', 'RASGRP3', 'MAP2K6']",0.9808237971245007,0,0,4
387,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9139498031355998,0.40416,0.03636616686435012,['ACSL1'],0.9808237971245007,0,0,1
388,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9139498031355998,0.40416,0.03636616686435012,['HDAC4'],0.9808237971245007,0,0,1
389,Mesodermal commitment pathway WP2857,0.9212796704802012,0.5215586428294681,0.042763442866895665,"['BHLHE40', 'RGS10', 'RPL38']",0.9808237971245007,0,0,3
390,Focal Adhesion WP306,0.9214087900821771,0.5855147361719657,0.04792525158536337,"['CCND3', 'PXN', 'PDGFB', 'IGF1', 'ACTG1']",0.9808237971245007,0,0,5
391,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9217115107573701,0.38855384615384614,0.031676074984157344,['ACTG1'],0.9808237971245007,0,0,1
392,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9220214112057658,0.4693649373881932,0.0381062528484685,"['CDKN1A', 'CYCS']",0.9808237971245007,0,0,2
393,Proteasome Degradation WP183,0.9277767322443047,0.4586247086247086,0.03438041851221685,"['H2AFZ', 'PSMB10']",0.9844348532973921,0,0,2
394,ATM Signaling Network in Development and Disease  WP3878,0.935200488205227,0.3606857142857143,0.02416390382557957,['HDAC4'],0.9872876040039993,0,0,1
395,Copper homeostasis WP3286,0.935200488205227,0.3606857142857143,0.02416390382557957,['ATOX1'],0.9872876040039993,0,0,1
396,TGF-beta Receptor Signaling WP560,0.9410478654749603,0.34819310344827586,0.021156656593400974,['STAT3'],0.9889504290156951,0,0,1
397,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9463683351831518,0.33653333333333335,0.01855086997774442,['MAP1LC3A'],0.9889504290156951,0,0,1
398,p53 transcriptional gene network WP4963,0.9463683351831518,0.33653333333333335,0.01855086997774442,['CDKN1A'],0.9889504290156951,0,0,1
399,Corticotropin-releasing hormone signaling pathway WP2355,0.947022476077186,0.4201388888888889,0.022869189944658926,"['HSP90AA1', 'TLR4']",0.9889504290156951,0,0,2
400,Energy Metabolism WP1541,0.951209307494562,0.3256258064516129,0.016288176869034637,['ESRRA'],0.9889504290156951,0,0,1
401,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9556139332035102,0.3154,0.014319564675691265,['GRIN2B'],0.9889504290156951,0,0,1
402,RANKL/RANK signaling pathway WP2018,0.9596214854852684,0.3057939393939394,0.012603712548863673,['MAP2K6'],0.9889504290156951,0,0,1
403,Integrated breast cancer pathway WP1984,0.9598847758572042,0.4847944833998373,0.0198484687670421,"['PLK3', 'FAU', 'BACH1', 'RASGRP3']",0.9889504290156951,0,0,4
404,Endometrial cancer WP4155,0.9632677078847298,0.2967529411764706,0.011105656005980668,['CDKN1A'],0.9889504290156951,0,0,1
405,Joubert Syndrome WP4656,0.9665851310197585,0.28822857142857145,0.009795708113040947,['RP2'],0.9889504290156951,0,0,1
406,DNA Repair Pathways Full Network WP4946,0.9695321025488746,0.36625874125874125,0.011332665299169173,"['POLB', 'APEX1']",0.9889504290156951,0,0,2
407,T-cell receptor (TCR) signaling pathway WP69,0.9695321025488746,0.36625874125874125,0.011332665299169173,"['CD83', 'MAP3K8']",0.9889504290156951,0,0,2
408,22q11.2 copy number variation syndrome WP4657,0.9696033611963784,0.2801777777777778,0.008648582865431414,['ARNTL'],0.9889504290156951,0,0,1
409,Ciliary landscape WP4352,0.9705110512508898,0.5359913181812577,0.016043554377822882,"['DOCK5', 'TBC1D4', 'IQGAP1', 'IQGAP2', 'DYNLL1', 'COX6C', 'CALM2']",0.9889504290156951,0,0,7
410,Genes related to primary cilium development (based on CRISPR) WP4536,0.9723493426773021,0.27256216216216217,0.007642679290325111,['DYNLL1'],0.9889504290156951,0,0,1
411,IL-3 signaling pathway WP286,0.9748475967765189,0.2653473684210526,0.00675949367688371,['STAT3'],0.9890789485542782,0,0,1
412,Ciliopathies WP4803,0.981212506709355,0.32991803278688525,0.006257298103473684,"['RP2', 'CCDC65']",0.9931204254800997,0,0,2
413,TGF-beta Signaling Pathway WP366,0.9845439149427643,0.372094405802271,0.005796031045100326,"['CDKN1A', 'LIMK2', 'MAP2K6']",0.9940794492279243,0,0,3
414,16p11.2 proximal deletion syndrome WP4949,0.9892801389424128,0.21422978723404254,0.002308911388300637,['MAP2K6'],0.9964488356014158,0,0,1
415,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9933284056180839,0.19347692307692307,0.0012951246461313153,['SEC24D'],0.998115530464436,0,0,1
416,Endoderm differentiation WP2853,0.9978644347362249,0.1569,0.00033542848221085206,['RGS10'],0.9989137508350779,0,0,1
417,mRNA Processing WP411,0.9989137508350779,0.21069500674763833,0.00022899166866585522,"['LSM7', 'SNRPD1']",0.9989137508350779,0,0,2
